An article in Healio
about a new UB study finding that a combination of anti-inflammatory and antithrombotic actions induced by IV insulin infusion could provide “potent inhibition” of the effects of COVID-19 in hospitalized patients quotes study co-authors Paresh Dandona
, SUNY Distinguished Professor and chief of endocrinology
, and Husam Ghanim
, research associate professor of endocrinology, both in the Jacobs School of Medicine and Biomedical Sciences. “Our data show that if you combine high doses of steroids with insulin, insulin takes away the pro-inflammatory effect of the steroid. In combination, you have a very nice, additive, potent mixture,” Dandona told Healio.